These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8765034)

  • 1. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.
    Lee SP; Thomas WA; Blake NW; Rickinson AB
    Eur J Immunol; 1996 Aug; 26(8):1875-83. PubMed ID: 8765034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
    Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
    Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma.
    Taylor GS; Haigh TA; Gudgeon NH; Phelps RJ; Lee SP; Steven NM; Rickinson AB
    J Virol; 2004 Jan; 78(2):768-78. PubMed ID: 14694109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.
    Ranieri E; Herr W; Gambotto A; Olson W; Rowe D; Robbins PD; Kierstead LS; Watkins SC; Gesualdo L; Storkus WJ
    J Virol; 1999 Dec; 73(12):10416-25. PubMed ID: 10559360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.
    Lorente E; García R; Mir C; Barriga A; Lemonnier FA; Ramos M; López D
    J Biol Chem; 2012 Mar; 287(13):9990-10000. PubMed ID: 22298786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
    Bollard CM; Gottschalk S; Torrano V; Diouf O; Ku S; Hazrat Y; Carrum G; Ramos C; Fayad L; Shpall EJ; Pro B; Liu H; Wu MF; Lee D; Sheehan AM; Zu Y; Gee AP; Brenner MK; Heslop HE; Rooney CM
    J Clin Oncol; 2014 Mar; 32(8):798-808. PubMed ID: 24344220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on TAP and its vital role in antigen presentation and cross-presentation.
    Mantel I; Sadiq BA; Blander JM
    Mol Immunol; 2022 Feb; 142():105-119. PubMed ID: 34973498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients.
    Hui EP; Taylor GS; Jia H; Ma BB; Chan SL; Ho R; Wong WL; Wilson S; Johnson BF; Edwards C; Stocken DD; Rickinson AB; Steven NM; Chan AT
    Cancer Res; 2013 Mar; 73(6):1676-88. PubMed ID: 23348421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma.
    Bollard CM; Gottschalk S; Helen Huls M; Leen AM; Gee AP; Rooney CM
    Cytotherapy; 2011 May; 13(5):518-22. PubMed ID: 21361747
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells.
    Chawla A; Alatrash G; Philips AV; Qiao N; Sukhumalchandra P; Kerros C; Diaconu I; Gall V; Neal S; Peters HL; Clise-Dwyer K; Molldrem JJ; Mittendorf EA
    Cancer Immunol Immunother; 2016 Jun; 65(6):741-51. PubMed ID: 27129972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.
    Xiao Z; Ye Z; Tadwal VS; Shen M; Ren EC
    Sci Rep; 2017 Jul; 7(1):5072. PubMed ID: 28698575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimerically fused antigen rich of overlapped epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a potential vaccine and diagnostic agent.
    Lin X; Chen S; Xue X; Lu L; Zhu S; Li W; Chen X; Zhong X; Jiang P; Sename TS; Zheng Y; Zhang L
    Cell Mol Immunol; 2016 Jul; 13(4):492-501. PubMed ID: 25864917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.
    Engelhard VH
    Int J Mass Spectrom; 2007 Jan; 259(1-3):32-39. PubMed ID: 18167512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK.
    Osorio Y; Mott KR; Jabbar AM; Moreno A; Foster TP; Kousoulas KG; Ghiasi H
    Virus Res; 2007 Sep; 128(1-2):71-80. PubMed ID: 17499382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction of primary lymphocytes with Epstein-Barr virus (EBV) latent membrane protein-specific T-cell receptor induces lysis of virus-infected cells: A novel strategy for the treatment of Hodgkin's disease and nasopharyngeal carcinoma.
    Jurgens LA; Khanna R; Weber J; Orentas RJ
    J Clin Immunol; 2006 Jan; 26(1):22-32. PubMed ID: 16418800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral transfer of T-cell receptor genes produces cells with a broad range of lytic activity.
    Orentas RJ; Bircher LA; Roskopf S
    Scand J Immunol; 2003 Jul; 58(1):33-42. PubMed ID: 12828556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP).
    de la Salle H; Saulquin X; Mansour I; Klayme S; Fricker D; Zimmer J; Cazenave JP; Hanau D; Bonneville M; Houssaint E; Lefranc G; Naman R
    Clin Exp Immunol; 2002 Jun; 128(3):525-31. PubMed ID: 12067308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
    J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells.
    Subklewe M; Paludan C; Tsang ML; Mahnke K; Steinman RM; Münz C
    J Exp Med; 2001 Feb; 193(3):405-11. PubMed ID: 11157061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.
    Münz C; Bickham KL; Subklewe M; Tsang ML; Chahroudi A; Kurilla MG; Zhang D; O'Donnell M; Steinman RM
    J Exp Med; 2000 May; 191(10):1649-60. PubMed ID: 10811859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.